BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25130809)

  • 1. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
    Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].
    Gritsaev SV; Martynkevich IS; Ziuzgin IS; Kariagina EV; Martynenko LS; Petrova EV; Tsybakova NIu; Ivanova MP; Kostroma II; Tiranova SA; Potikhonova NA; Abdulkadyrov KM
    Ter Arkh; 2014; 86(7):45-52. PubMed ID: 25314777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of acute myeloid leukemia with t (16;21) (p11;q22):nine cases report and literature review].
    Ouyang M; Xu LP; Wang Y; Zhu HH; Qin YZ; Lai YY; Liu YR; Jiang B; Huang XJ; Jiang H
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):210-5. PubMed ID: 27033758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature.
    Sugimoto Y; Nishii K; Sakakura M; Araki H; Usui E; Lorenzo V F; Hoshino N; Miyashita H; Ohishi K; Katayama N; Shiku H
    Hematol J; 2004; 5(1):84-9. PubMed ID: 14745436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
    Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
    Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
    Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
    Byrd JC; Dodge RK; Carroll A; Baer MR; Edwards C; Stamberg J; Qumsiyeh M; Moore JO; Mayer RJ; Davey F; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1999 Dec; 17(12):3767-75. PubMed ID: 10577848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is translocation (8;21) a "favorable" cytogenetic rearrangement in acute myeloid leukemia?
    Fenaux P; Laï JL; Preudhomme C; Jouet JP; Deminatti M; Bauters F
    Nouv Rev Fr Hematol (1978); 1990; 32(3):179-82. PubMed ID: 2216701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
    Huang L; Abruzzo LV; Valbuena JR; Medeiros LJ; Lin P
    Am J Clin Pathol; 2006 Feb; 125(2):267-72. PubMed ID: 16393685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective analysis of treatment outcomes in 70 patients with t(8;21) acute myeloid leukemia].
    Numata A; Fujimaki K; Aoshima T; Onizuka M; Hagihara M; Miyazaki K; Fujita H; Sakai R; Machida S; Tanaka E; Nakajima Y; Hattori Y; Tanaka M; Yamazaki E; Shirasugi Y; Inoue Y; Watanabe S; Fujisawa S
    Rinsho Ketsueki; 2012 Jul; 53(7):698-704. PubMed ID: 22975772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
    Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
    Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and experimental characteristics of 20 patients with acute myeloid leukemia with complex variant of t(8; 21)].
    Xia J; Chen SN; Pan JL; Wang QR; Wu YF; Wang Y; Zhang J; Shen J; Xue YQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):815-20. PubMed ID: 23998566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
    Byrd JC; Weiss RB; Arthur DC; Lawrence D; Baer MR; Davey F; Trikha ES; Carroll AJ; Tantravahi R; Qumsiyeh M; Patil SR; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 Feb; 15(2):466-75. PubMed ID: 9053467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience.
    Ruiz-Argüelles GJ; Morales-Toquero A; Manzano C; Ruiz-Delgado GJ; Jaramillo P; Gonzalez-Carrillo ML; Reyes-Núñez V
    Hematology; 2006 Aug; 11(4):235-8. PubMed ID: 17178661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare cytogenetic presentation of acute myeloid leukemia (AML-M2).
    Kumari P; LingappaKavitha B; Obula Reddy C; Mangalagowri M; Madhumathi DS; Mahadeva Prasad M; Raghavendra HV; Premalata CS; Lakshmaiah KC; Mir Mazloumi SH
    Acta Med Iran; 2012; 50(12):827-30. PubMed ID: 23456526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature.
    Kim H; Moon HW; Hur M; Yun YM; Lee MH
    Acta Haematol; 2011; 125(4):237-41. PubMed ID: 21325813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22).
    Chen CC; Gau JP; Yu YB; Lu CH; Lee KD; You JY
    Adv Ther; 2007; 24(4):907-20. PubMed ID: 17901040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.